Skip to content
TrialScanner

NCT06603623

Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine

Phase 2CompletedBHVNLead

Registry record

Lead sponsor
Biohaven Therapeutics Ltd.
Conditions
Migraine
Primary completion
Mar 24, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06603623 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06603623: Efficacy and Safety Trial of... | TrialScanner